https://www.pharmanow.live/latest-news/cervavac-who-prequalification-serum-institute 2026-10-14T11:50:48+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 CERVAVAC WHO Prequalification Secured by Serum Institute CERVAVAC WHO prequalification https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/cervavac-who-prequalification-hpv-vaccine20261014115040.webp https://www.pharmanow.live/latest-news/bix-2026-counts-down-to-opening-with-post-glp-1-session-on-the-next-obesity-treatment-market 2026-10-14T10:45:02+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 BIX 2026 Counts Down to Opening with Post-GLP-1 Session on the Next Obesity Treatment Market BIX 2026, BIOPLUS INTERPHEX KOREA 2026, Post-GLP-1 obesity market, next-generation obesity treatments, BIX 2026 conference schedule https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/BIX2026Photo20261014104350.png https://www.pharmanow.live/latest-news/eurofins-sf-analytical-laboratories-fda-warning-letter-microbial-data-integrity-2026 2026-10-14T11:37:15+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Eurofins SF Analytical Laboratories FDA Warning Letter Issued Eurofins SF Analytical Laboratories FDA warning letter https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/eurofins-sf-analytical-laboratories-fda-warning-letter20261014113516.webp https://www.pharmanow.live/latest-news/lovelace-biomedical-fda-warning-letter-glp-raw-data-reconciliation-2026 2026-10-14T11:31:03+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Lovelace Biomedical FDA Warning Letter Cites GLP Data Failures Lovelace Biomedical FDA warning letter https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/lovelace-biomedical-fda-warning-letter20261014112901.webp https://www.pharmanow.live/latest-news/hanlim-pharm-fda-warning-letter-aseptic-failures-sterile-fill-finish-2026 2026-10-14T11:24:50+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Hanlim Pharm FDA Warning Letter Cites Aseptic Failures Hanlim Pharm FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/hanlim-pharm-fda-warning-letter20261014112229.webp https://www.pharmanow.live/latest-news/sca-pharmaceuticals-fda-warning-letter-503b-sterile-compounding-cgmp-2026 2026-10-14T11:17:28+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 SCA Pharmaceuticals Receives FDA Warning Letter Over CGMP Gaps SCA Pharmaceuticals receives FDA warning letter https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/sca-pharmaceuticals-fda-warning-letter-503b-cgmp-failures-202620261014111724.webp https://www.pharmanow.live/latest-news/bristol-myers-squibb-ryz101-phase-3-primary-endpoint-neuroendocrine-cancer 2026-10-14T11:04:24+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Bristol Myers Squibb’s RYZ101 Meets Phase 3 Endpoint in GEP-NETs Bristol Myers Squibb’s RYZ101, BMS RYZ101 https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/bms-ryz101-phase-3-endpoint-neuroendocrine-cancer-202620261014110417.webp https://www.pharmanow.live/latest-news/phio-pharmaceuticals-completes-first-commercial-scale-cgmp-batch-ph-762 2026-10-14T11:00:01+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Phio Pharmaceuticals Completes PH-762 Commercial-Scale Batch Phio Pharmaceuticals https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/phio-pharmaceuticals-commercial-scale-cgmp-batch-ph-762-202620261014105843.webp https://www.pharmanow.live/latest-news/lonza-qurient-exclusive-deal-dual-payload-adc-cancer-therapies 2026-10-14T10:55:18+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Lonza-Qurient Deal Expands Dual-Payload ADC Technology Lonza-Qurient https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/lonza-qurient-dual-payload-adc-cancer-therapies-202620261014105508.webp https://www.pharmanow.live/latest-news/perceptive-discovery-nucleus-radiopharma-partnership-radiopharmaceutical-development 2026-10-14T10:48:56+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Perceptive Discovery Partners With Nucleus RadioPharma Perceptive Discovery https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/perceptive-discovery-nucleus-radiopharma-partnership-radiopharmaceutical-development-202620261014104606.webp https://www.pharmanow.live/latest-news/zydus-formycon-fda-accepts-first-pembrolizumab-biosimilar-bla-review 2026-10-14T10:40:49+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Zydus & Formycon Secure FDA Review for Pembrolizumab Biosimilar Zydus & Formycon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/zydus-formycon-fda-accepts-first-pembrolizumab-biosimilar-bla-review-202620261014103722.webp https://www.pharmanow.live/latest-news/dr-reddys-fto-11-andhra-pradesh-fda-form-483-observations 2026-10-13T11:26:29+05:30 Pharma Now en 2026-10-12T00:00:00+05:30 Dr. Reddy's FTO-11 Plant Receives Two FDA Form 483 Observations After Andhra Pradesh Inspection Dr. Reddy's https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/dr-reddys-fto-11-andhra-pradesh-fda-form-483-observations-202620261013112445.webp https://www.pharmanow.live/latest-news/cadila-pharmaceuticals-appoints-nirav-gandhi-president 2026-10-13T11:15:53+05:30 Pharma Now en 2026-10-12T00:00:00+05:30 Cadila Pharmaceuticals Appoints Nirav Gandhi as President Amid US Market Push Cadila https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/cadila-pharmaceuticals-nirav-gandhi-president-202620261013111539.webp